BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 31533663)

  • 1. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
    Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
    BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
    Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
    BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
    Happel AU; Singh R; Mitchev N; Mlisana K; Jaspan HB; Barnabas SL; Passmore JS
    BMC Infect Dis; 2020 Jul; 20(1):491. PubMed ID: 32650729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a yoghurt drink containing Lactobacillus strains on bacterial vaginosis in women - a double-blind, randomised, controlled clinical pilot trial.
    Laue C; Papazova E; Liesegang A; Pannenbeckers A; Arendarski P; Linnerth B; Domig KJ; Kneifel W; Petricevic L; Schrezenmeir J
    Benef Microbes; 2018 Jan; 9(1):35-50. PubMed ID: 29065710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.
    Anukam KC; Osazuwa E; Osemene GI; Ehigiagbe F; Bruce AW; Reid G
    Microbes Infect; 2006 Oct; 8(12-13):2772-6. PubMed ID: 17045832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally administrated
    Qi F; Fan S; Fang C; Ge L; Lyu J; Huang Z; Zhao S; Zou Y; Huang L; Liu X; Liang Y; Zhang Y; Zhong Y; Zhang H; Xiao L; Zhang X
    Front Immunol; 2023; 14():1125239. PubMed ID: 37575226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and complete genome sequences of L. rhamnosus DSM 14870 and L. gasseri DSM 14869 contained in the EcoVag
    Marcotte H; Krogh Andersen K; Lin Y; Zuo F; Zeng Z; Larsson PG; Brandsborg E; Brønstad G; Hammarström L
    Microbiol Res; 2017 Dec; 205():88-98. PubMed ID: 28942850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study.
    Larsson PG; Stray-Pedersen B; Ryttig KR; Larsen S
    BMC Womens Health; 2008 Jan; 8():3. PubMed ID: 18197974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
    Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
    Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.
    Heczko PB; Tomusiak A; Adamski P; Jakimiuk AJ; Stefański G; Mikołajczyk-Cichońska A; Suda-Szczurek M; Strus M
    BMC Womens Health; 2015 Dec; 15():115. PubMed ID: 26635090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
    Vicariotto F; Mogna L; Del Piano M
    J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial.
    Anukam K; Osazuwa E; Ahonkhai I; Ngwu M; Osemene G; Bruce AW; Reid G
    Microbes Infect; 2006 May; 8(6):1450-4. PubMed ID: 16697231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05.
    Ngugi BM; Hemmerling A; Bukusi EA; Kikuvi G; Gikunju J; Shiboski S; Fredricks DN; Cohen CR
    Sex Transm Dis; 2011 Nov; 38(11):1020-7. PubMed ID: 21992977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial.
    Russo R; Karadja E; De Seta F
    Benef Microbes; 2019 Feb; 10(1):19-26. PubMed ID: 30525953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
    Bradshaw CS; Pirotta M; De Guingand D; Hocking JS; Morton AN; Garland SM; Fehler G; Morrow A; Walker S; Vodstrcil LA; Fairley CK
    PLoS One; 2012; 7(4):e34540. PubMed ID: 22509319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics in the prevention of recurrences of bacterial vaginosis.
    Parma M; Stella Vanni V; Bertini M; Candiani M
    Altern Ther Health Med; 2014; 20 Suppl 1():52-7. PubMed ID: 24473986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterisation of vaginal lactobacilli from South African women.
    Pendharkar S; Magopane T; Larsson PG; de Bruyn G; Gray GE; Hammarström L; Marcotte H
    BMC Infect Dis; 2013 Jan; 13():43. PubMed ID: 23351177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent Lactobacilli-containing Vaginal Probiotic or Metronidazole Use to Prevent Bacterial Vaginosis Recurrence: A Pilot Study Incorporating Microscopy and Sequencing.
    van de Wijgert JHHM; Verwijs MC; Agaba SK; Bronowski C; Mwambarangwe L; Uwineza M; Lievens E; Nivoliez A; Ravel J; Darby AC
    Sci Rep; 2020 Mar; 10(1):3884. PubMed ID: 32127550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis.
    Happel AU; Kullin B; Gamieldien H; Wentzel N; Zauchenberger CZ; Jaspan HB; Dabee S; Barnabas SL; Jaumdally SZ; Dietrich J; Gray G; Bekker LG; Froissart R; Passmore JS
    PLoS Pathog; 2020 Jun; 16(6):e1008559. PubMed ID: 32497109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV.
    Hummelen R; Changalucha J; Butamanya NL; Cook A; Habbema JD; Reid G
    Int J Gynaecol Obstet; 2010 Dec; 111(3):245-8. PubMed ID: 20801446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.